The biosignatures of human endometriosis with and without GnRH agonist treatment

Endah Rahmawati, Pawan Kumar Maurya, A.-P. Kao, H.-W. Chen, Chii‐Ruey Tzeng
In: Fertility and Sterility · 2013 · vol. 100(3) , pp. S362–S363 · doi:10.1016/j.fertnstert.2013.07.767 · W1973785549
article OA: closed CC0 ⤵ 1 in-corpus citation
Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".
View at publisher → View on OpenAlex
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-09 ⓘ

This study identified molecular biosignatures in human endometriosis lesions, comparing samples from patients treated with GnRH agonists to those who were not.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

endometriosis

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cited by (1)

Cited by (1)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
unpaywall
last seen: 2026-08-14T06:25:32.811723+00:00
License: CC0 · commercial use OK